Sign In
Buy JNJ
$241.00
+1.92 (+0.80%)
At Close: Jun 24, 2026
Johnson & Johnson: A Very Cautious 'Buy'
05:46pm, Monday, 18'th Sep 2023
Johnson & Johnson reported solid second quarter results - with MedTech reporting double-digit growth - and raised its full-year guidance for fiscal 2023. Kenvue is now a stand-alone company, and inves
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
04:30pm, Monday, 18'th Sep 2023
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, October 17th to review third-quarter results. Jose
Johnson & Johnson's Reinvention - Is A New Logo Enough?
07:35am, Monday, 18'th Sep 2023
Johnson & Johnson's strategic transformation, marked by the split-off of its consumer health division, is a significant shift in its corporate strategy. The company aims to streamline its operations,
Johnson & Johnson: Kenvue Spin-Off Unlikely To Drive Market-Beating Returns
12:58am, Monday, 18'th Sep 2023
Johnson & Johnson had spun off Kenvue, its consumer health division, to boost growth in its more profitable pharmaceutical and medical technology sectors. JNJ achieved a steady 3.3% revenue growth ove
Johnson & Johnson: AAA-Rated And Potentially 20% Undervalued
07:02am, Sunday, 17'th Sep 2023
Johnson & Johnson is attractively valued and well-positioned for long-term growth, with a 3.0% dividend yield and a AAA-rated balance sheet. The company has faced challenges due to the baby powder con
Johnson & Johnson ditching script logo after 130 years
04:25pm, Thursday, 14'th Sep 2023
Johnson & Johnson announced that it's ditching the classic cursive script it has used for 130 years in favor of a revamped logo that pays homage to the old design.
3 Blue-Chip Stocks to Watch in the ‘Green Zone'
03:05pm, Thursday, 14'th Sep 2023
Blue-chip stocks represent ownership in established, financially sound businesses, but are the blue-chips you're taking a look at today in the “Green Zone stocks” category? TradeSmith offers inves
Johnson & Johnson is replacing its iconic logo
02:54pm, Thursday, 14'th Sep 2023
Johnson & Johnson is replacing its instantly recognizable logo that's been in use for 135 years.
Johnson & Johnson is ditching its iconic script logo after 130 years — here's what they're using instead
01:49pm, Thursday, 14'th Sep 2023
Johnson & Johnson said Thursday that it will replace the well-known signature script with a modern look that reflects its sharpened focus on pharmaceuticals and medical devices.
J&J, P&G sued after FDA panel ruling on cold medicine decongestant
12:58pm, Thursday, 14'th Sep 2023
A new lawsuit accuses Johnson & Johnson and Procter & Gamble of deceiving consumers about decongestant cold medicines containing an ingredient that a unanimous U.S. Food and Drug Administration adviso
Buy the Dip: 3 Healthcare Stocks to Snag Now for Supercharged Gains
04:23pm, Wednesday, 13'th Sep 2023
In the ever-evolving landscape of investing, the spotlight is on the top healthcare stocks to buy on the dip. The healthcare sector is highly known for its robust resilience and incredible growth pote
Here's My Top Growth Stock to Buy in 2023
07:41am, Wednesday, 13'th Sep 2023
Roku's stock price has fallen 83% from its peak in 2021. The rocket-powered growth stock trades at just 3.7 times sales, which is comparable to many sleepy value investments.
Better Buy: J&J vs. Kenvue
05:30am, Wednesday, 13'th Sep 2023
Johnson & Johnson recently spun off its consumer health unit into a new company called Kenvue. The consumer health segment weighed on J&J's growth, but it could progress successfully as an independent
Key drug in Sudafed, Dayquil and many other decongestants doesn't relieve congestion: FDA
03:32pm, Tuesday, 12'th Sep 2023
WASHINGTON (AP) — The leading decongestant used by millions of Americans looking for relief from a stuffy nose is no better than a dummy pill, according to government experts who reviewed the latest
Doctor asks court to toss J&J lawsuit against her over cancer research
07:57pm, Monday, 11'th Sep 2023
A medical researcher has asked a court to throw out a lawsuit that Johnson & Johnson filed against her over her 2019 study on the links between cosmetic talc products and cancer, saying that her resea
